Fidelity Disruptive Medicine ETF (FMED)
NASDAQ: FMED · Real-Time Price · USD
27.79
+0.07 (0.25%)
Jan 9, 2026, 4:00 PM EST - Market closed

FMED Holdings Information

FMED is an equity ETF with a total of 75 individual holdings. The top holdings are Fidelity Securities Lending Cash Central Fund stock at 4.63%, Boston Scientific at 4.54%, UCB SA at 3.79%, argenx SE at 3.77%, and Alnylam Pharmaceuticals at 3.76%.

Total Holdings
75
Top 10 Percentage
36.49%
Asset Class
Equity
ETF Category
Health
Assets
65.24M
PE Ratio
43.97

Sector Allocation

Top 25 Holdings

No.SymbolName WeightShares
1n/aFidelity Securities Lending Cash Central Fund4.63%2,983,450
2BSXBoston Scientific Corporation4.54%29,735
3EBR: UCBUCB SA3.79%8,299
4ARGXargenx SE3.77%3,053
5ALNYAlnylam Pharmaceuticals, Inc.3.76%6,060
6DHRDanaher Corporation3.57%9,778
7COGTCogent Biosciences, Inc.3.46%62,698
8ISRGIntuitive Surgical, Inc.3.09%3,399
9VEEVVeeva Systems Inc.2.97%7,941
10PENPenumbra, Inc.2.92%5,964
11PODDInsulet Corporation2.90%6,372
12WAYWaystar Holding Corp.2.43%47,322
13LFSTLifeStance Health Group, Inc.2.37%206,792
14EWEdwards Lifesciences Corporation2.29%17,421
15EPA: DIMSartorius Stedim Biotech S.A.2.20%5,513
16n/aFidelity Cash Central Fund1.99%1,283,624
17TMOThermo Fisher Scientific Inc.1.92%2,036
18MASIMasimo Corporation1.90%8,882
19LLYEli Lilly and Company1.73%1,030
20SYKStryker Corporation1.67%2,925
21LEGNLegend Biotech Corporation1.61%45,084
22UNHUnitedHealth Group Incorporated1.60%2,973
23PCVXVaxcyte, Inc.1.58%22,513
24CRNXCrinetics Pharmaceuticals, Inc.1.57%19,000
25NTRANatera, Inc.1.55%4,179
Showing 25 of 75 holdings
Subscribe to see the full list
As of Jan 8, 2026